• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ECL2 在 CGRP 受体激活中的作用:综合建模与实验研究方法。

The role of ECL2 in CGRP receptor activation: a combined modelling and experimental approach.

机构信息

Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.

出版信息

J R Soc Interface. 2013 Sep 18;10(88):20130589. doi: 10.1098/rsif.2013.0589. Print 2013 Nov 6.

DOI:10.1098/rsif.2013.0589
PMID:24047872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3785825/
Abstract

The calcitonin gene-related peptide (CGRP) receptor is a complex of a calcitonin receptor-like receptor (CLR), which is a family B G-protein-coupled receptor (GPCR) and receptor activity modifying protein 1. The role of the second extracellular loop (ECL2) of CLR in binding CGRP and coupling to Gs was investigated using a combination of mutagenesis and modelling. An alanine scan of residues 271-294 of CLR showed that the ability of CGRP to produce cAMP was impaired by point mutations at 13 residues; most of these also impaired the response to adrenomedullin (AM). These data were used to select probable ECL2-modelled conformations that are involved in agonist binding, allowing the identification of the likely contacts between the peptide and receptor. The implications of the most likely structures for receptor activation are discussed.

摘要

降钙素基因相关肽 (CGRP) 受体是降钙素受体样受体 (CLR) 的复合物,CLR 是 B 族家族 G 蛋白偶联受体 (GPCR) 和受体活性修饰蛋白 1。使用突变和建模相结合的方法研究了 CLR 的第二细胞外环 (ECL2) 在结合 CGRP 和与 Gs 偶联中的作用。对 CLR 的 271-294 位残基进行丙氨酸扫描表明,CGRP 产生 cAMP 的能力因 13 个残基的点突变而受损;其中大多数也损害了对肾上腺髓质素 (AM) 的反应。这些数据用于选择可能的 ECL2 建模构象,这些构象涉及激动剂结合,从而确定肽和受体之间的可能接触。讨论了最可能的结构对受体激活的影响。

相似文献

1
The role of ECL2 in CGRP receptor activation: a combined modelling and experimental approach.ECL2 在 CGRP 受体激活中的作用:综合建模与实验研究方法。
J R Soc Interface. 2013 Sep 18;10(88):20130589. doi: 10.1098/rsif.2013.0589. Print 2013 Nov 6.
2
Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.受体活性修饰蛋白依赖性突变对降钙素受体样受体的影响:对肾上腺髓质素和降钙素基因相关肽药理学的影响。
Br J Pharmacol. 2014 Feb;171(3):772-88. doi: 10.1111/bph.12508.
3
Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs.降钙素基因相关肽和肾上腺髓质素受体与Gs偶联中依赖和不依赖受体活性修饰蛋白的激活机制
Biochem Pharmacol. 2017 Oct 15;142:96-110. doi: 10.1016/j.bcp.2017.07.005. Epub 2017 Jul 11.
4
Understanding the molecular functions of the second extracellular loop (ECL2) of the calcitonin gene-related peptide (CGRP) receptor using a comprehensive mutagenesis approach.使用全面的诱变方法了解降钙素基因相关肽(CGRP)受体第二细胞外环(ECL2)的分子功能。
Mol Cell Endocrinol. 2017 Oct 15;454:39-49. doi: 10.1016/j.mce.2017.05.034. Epub 2017 May 30.
5
Relative Antagonism of Mutants of the CGRP Receptor Extracellular Loop 2 Domain (ECL2) Using a Truncated Competitive Antagonist (CGRP): Evidence for the Dual Involvement of ECL2 in the Two-Domain Binding Model.使用截短的竞争性拮抗剂(CGRP)对降钙素基因相关肽(CGRP)受体细胞外环2结构域(ECL2)突变体的相对拮抗作用:ECL2在双结构域结合模型中双重作用的证据
Biochemistry. 2017 Aug 1;56(30):3877-3880. doi: 10.1021/acs.biochem.7b00077. Epub 2017 Jul 18.
6
Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.通过连接的 RAMP-降钙素受体样受体细胞外域融合蛋白对 CGRP 和肾上腺髓质素肽的选择性结合。
Protein Sci. 2013 Dec;22(12):1775-85. doi: 10.1002/pro.2377. Epub 2013 Oct 19.
7
Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor.G蛋白偶联受体依赖受体活性修饰蛋白的选择性肽识别的结构基础
Mol Cell. 2015 Jun 18;58(6):1040-52. doi: 10.1016/j.molcel.2015.04.018. Epub 2015 May 14.
8
The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling.人类降钙素受体样受体的第三个细胞外环对于肾上腺髓质素信号的激活至关重要。
Br J Pharmacol. 2012 May;166(1):137-50. doi: 10.1111/j.1476-5381.2011.01803.x.
9
Photoaffinity Cross-Linking and Unnatural Amino Acid Mutagenesis Reveal Insights into Calcitonin Gene-Related Peptide Binding to the Calcitonin Receptor-like Receptor/Receptor Activity-Modifying Protein 1 (CLR/RAMP1) Complex.光亲和交联与非天然氨基酸诱变揭示降钙素基因相关肽与降钙素受体样受体/受体活性修饰蛋白1(CLR/RAMP1)复合物结合的见解。
Biochemistry. 2018 Aug 14;57(32):4915-4922. doi: 10.1021/acs.biochem.8b00502. Epub 2018 Jul 25.
10
Structure-function analysis of RAMP1 by alanine mutagenesis.通过丙氨酸诱变对RAMP1进行结构-功能分析。
Biochemistry. 2009 Jan 13;48(1):198-205. doi: 10.1021/bi801869n.

引用本文的文献

1
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond.降钙素基因相关肽的生理学、药理学和治疗靶点:偏头痛及其他。
Physiol Rev. 2023 Apr 1;103(2):1565-1644. doi: 10.1152/physrev.00059.2021. Epub 2022 Dec 1.
2
Sustained Activation of CLR/RAMP Receptors by Gel-Forming Agonists.凝胶形成激动剂对 CLR/RAMP 受体的持续激活。
Int J Mol Sci. 2022 Nov 2;23(21):13408. doi: 10.3390/ijms232113408.
3
Molecular Signature for Receptor Engagement in the Metabolic Peptide Hormone Amylin.代谢肽激素胰淀素受体结合的分子特征

本文引用的文献

1
Eukaryotic G protein signaling evolved to require G protein-coupled receptors for activation.真核 G 蛋白信号转导进化需要 G 蛋白偶联受体来激活。
Sci Signal. 2013 May 21;6(276):ra37. doi: 10.1126/scisignal.2003768.
2
Heterotrimeric G protein signalling in the plant kingdom.植物王国中的异三聚体 G 蛋白信号转导。
Open Biol. 2013 Mar 27;3(3):120186. doi: 10.1098/rsob.120186.
3
Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations.极性跨膜相互作用驱动配体特异性和信号通路偏向的家族 B G 蛋白偶联受体构象的形成。
ACS Pharmacol Transl Sci. 2018 Apr 23;1(1):32-49. doi: 10.1021/acsptsci.8b00002. eCollection 2018 Sep 14.
4
Dawn of a New RAMPage.新 RAMPage 的黎明。
Trends Pharmacol Sci. 2020 Apr;41(4):249-265. doi: 10.1016/j.tips.2020.01.009. Epub 2020 Feb 27.
5
Development of chimeric and bifunctional antagonists for CLR/RAMP receptors.CLR/RAMP 受体嵌合和双功能拮抗剂的研制。
PLoS One. 2019 May 31;14(5):e0216996. doi: 10.1371/journal.pone.0216996. eCollection 2019.
6
Cryo-EM structure of the active, G-protein complexed, human CGRP receptor.活性态、与 G 蛋白复合物结合的人降钙素基因相关肽受体的冷冻电镜结构。
Nature. 2018 Sep;561(7724):492-497. doi: 10.1038/s41586-018-0535-y. Epub 2018 Sep 12.
7
Extracellular loops 2 and 3 of the calcitonin receptor selectively modify agonist binding and efficacy.钙受体细胞外环 2 和 3 选择性修饰激动剂结合和效能。
Biochem Pharmacol. 2018 Apr;150:214-244. doi: 10.1016/j.bcp.2018.02.005. Epub 2018 Feb 16.
8
Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs.降钙素基因相关肽和肾上腺髓质素受体与Gs偶联中依赖和不依赖受体活性修饰蛋白的激活机制
Biochem Pharmacol. 2017 Oct 15;142:96-110. doi: 10.1016/j.bcp.2017.07.005. Epub 2017 Jul 11.
9
Key interactions by conserved polar amino acids located at the transmembrane helical boundaries in Class B GPCRs modulate activation, effector specificity and biased signalling in the glucagon-like peptide-1 receptor.位于B类G蛋白偶联受体跨膜螺旋边界的保守极性氨基酸的关键相互作用调节胰高血糖素样肽-1受体的激活、效应器特异性和偏向性信号传导。
Biochem Pharmacol. 2016 Oct 15;118:68-87. doi: 10.1016/j.bcp.2016.08.015. Epub 2016 Aug 26.
10
Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties.受体活性修饰蛋白2和3产生具有不同分子特性的肾上腺髓质素受体亚型。
J Biol Chem. 2016 May 27;291(22):11657-75. doi: 10.1074/jbc.M115.688218. Epub 2016 Mar 24.
Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5211-6. doi: 10.1073/pnas.1221585110. Epub 2013 Mar 11.
4
The importance of interactions with helix 5 in determining the efficacy of β-adrenoceptor ligands.确定β-肾上腺素受体配体疗效的关键在于与螺旋 5 的相互作用。
Biochem Soc Trans. 2013 Feb 1;41(1):159-65. doi: 10.1042/BST20120228.
5
"Round up the usual suspects": a comment on nonexistent plant G protein-coupled receptors.“围捕嫌疑犯”:对不存在的植物 G 蛋白偶联受体的评论。
Plant Physiol. 2013 Mar;161(3):1097-102. doi: 10.1104/pp.112.212324. Epub 2013 Jan 8.
6
GPCR activation: a mutagenic spotlight on crystal structures.G 蛋白偶联受体的激活:晶体结构中的诱变焦点。
Trends Pharmacol Sci. 2013 Jan;34(1):67-84. doi: 10.1016/j.tips.2012.11.002. Epub 2012 Dec 13.
7
Similarity between class A and class B G-protein-coupled receptors exemplified through calcitonin gene-related peptide receptor modelling and mutagenesis studies.通过降钙素基因相关肽受体建模和突变研究示例说明 A 类和 B 类 G 蛋白偶联受体之间的相似性。
J R Soc Interface. 2012 Dec 12;10(79):20120846. doi: 10.1098/rsif.2012.0846. Print 2013 Feb.
8
High-resolution crystal structure of human protease-activated receptor 1.人蛋白酶激活受体 1 的高分辨率晶体结构。
Nature. 2012 Dec 20;492(7429):387-92. doi: 10.1038/nature11701. Epub 2012 Dec 9.
9
Structure-activity relationships for α-calcitonin gene-related peptide.α-降钙素基因相关肽的构效关系。
Br J Pharmacol. 2013 Dec;170(7):1308-22. doi: 10.1111/bph.12072.
10
Structure-function of the G protein-coupled receptor superfamily.G 蛋白偶联受体超家族的结构与功能。
Annu Rev Pharmacol Toxicol. 2013;53:531-56. doi: 10.1146/annurev-pharmtox-032112-135923. Epub 2012 Nov 8.